Showing results (121-130 of 773) with videos related to
Sort By:
Pageof 78
Health Services Research|September 13, 2003
Improved comorbidity adjustment for predicting mortality in Medicare populationsSebastian Schneeweiss, Philip S Wang, Jerry Avorn, et al.Plos Medicine|March 18, 2015
Paying physicians to prescribe generic drugs and follow-on biologics in the United StatesAmeet Sarpatwari, Niteesh K Choudhry, Jerry Avorn, et al.JAMA Network Open|November 8, 2022
Variations in Use of Diabetes Drugs With Cardiovascular Benefits Among Medicaid PatientsMike Z Zhai, Jerry Avorn, Jun Liu, et al.Contraception|January 26, 2016
Trends in direct-to-consumer advertising of prescription contraceptivesMin H Wu, Deborah Bartz, Jerry Avorn, et al.Journal of the American Society of Nephrology : JASN|January 23, 2003
A propensity analysis of late versus early nephrologist referral and mortality on dialysisWolfgang C Winkelmayer, William F Owen, Raisa Levin, et al.The Milbank Quarterly|August 10, 2021
Pursuing Value-Based Prices for Drugs: A Comprehensive Comparison of State Prescription Drug-Pricing BoardsLiam Bendicksen, Benjamin N Rome, Jerry Avorn, et al.Circulation|November 26, 2009
Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndromeJeremy A Rassen, Niteesh K Choudhry, Jerry Avorn, et al.Plos Medicine|August 18, 2012
Conflict of interest reporting by authors involved in promotion of off-label drug use: an analysis of journal disclosuresAaron S Kesselheim, Bo Wang, David M Studdert, et al.Nature Clinical Practice. Endocrinology & Metabolism|July 3, 2008
Will absolute fracture risk prediction facilitate treatment of osteoporosis?Daniel H SolomonJournal of Managed Care Pharmacy : JMCP|March 24, 2007
The comparative safety and effectiveness of TNF-alpha antagonists [corrected]Daniel H SolomonPageof 78